Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesLaboratory/PathologyMeridian COVID-19 Test Quantity Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentMeridianPolicy MDN.CP.PMN.357

    COVID-19 Test Quantity Limit

    Customize your policy alerts

    Sign up for meridian Policy MDN.CP.PMN.357 alerts

    Get alerted when Policy MDN.CP.PMN.357 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity and approval criteria for coverage of COVID-19 test kits in excess of the standard allowance for Meridian (Medicaid) members, and documents required from providers to support such requests.

    Policy Summary
    PayerMeridian
    PolicyCOVID-19 Test Quantity Limit
    Policy CodePolicy MDN.CP.PMN.357
    Change TypeNo material changes
    Effective DateSep 1, 2026
    Last ReviewJul 10, 2026
    Next Review DateJul 10, 2026
    Key ActionSubmit prior authorization and supporting clinical documentation for requests exceeding 8 COVID-19 test kits per 365 days.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    8standard kits per 365 days
    365dtime period
    3 monthsmax approval duration
    Medicaidline of business

    Coverage Criteria for Excess COVID-19 Test Kits

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    inv-01: Initial Approval Criteria — Excess Tests

    COVID-19 test kits in excess of 8 kits per 365 days are medically necessary when ONE of the following initial criteria is met:

    Initial approval (A): Member meets at least one of: 1) Immunocompromised status (e.g., transplant recipient, active cancer treatment, advanced immunodeficiency); 2) Documentation of need for frequent testing ordered by a provider due to a chronic condition or high‑risk medical status; 3) Recent exposure or recurring symptoms requiring serial testing; 4) Residence or employment in a high‑risk setting where frequent testing is medically necessary.>=1

    Approval duration: duration of request or 3 months (whichever is less)

    inv-02: Continued Therapy Criteria — Excess Tests

    Continued therapy for coverage of >8 tests/365 days (renewal):

    Continued therapy (A): 1) Member was previously authorized to receive >8 COVID‑19 test kits in a 365‑day period via Centene benefit OR member has previously met the initial approval criteria; AND 2) Provider submits a letter of medical necessity detailing why the member must continue testing.all

    Approval duration: duration of request or 3 months (whichever is less)

    Coverage for indications that are not FDA‑approved is not authorized under this policy unless the provider submits sufficient documentation demonstrating efficacy and safety in accordance with Meridian’s Off‑label Use Policy (CP.PMN.53) or other applicable evidence of coverage documents. Requests for off‑label use should follow the requirements described in the off‑label policy to be considered for coverage.

    Standard Allowance and Frequency Limits

    Standard test kit allowance
    Standard allowance8 kits per 365 days
    Time period for count365 days
    When excess criteria applyRequests for quantities >8 kits/365 days require documentation that approval criteria are met
    Approval duration for excess authorizationsDuration requested or 3 months (whichever is less)
    at‑home OTC COVID‑19 test kits (primarily antigen tests)
    Test setting and authorizationOver-the-counter, at-home diagnostic tests authorized by the FDA for self-testing
    Typical technologyPrimarily antigen tests that detect viral proteins
    Turnaround timeTypically provide results in 15–30 minutes
    Use without prescriptionAuthorized for self-testing and can be used without a prescription

    Prior Authorization and Documentation Requirements

    Prior Authorization

    Prior authorization required for quantities >8 kits/365 days

    Prior authorization is required for any request that exceeds the standard allowance of 8 COVID-19 test kits per 365 days. Approval duration will be the duration requested or 3 months, whichever is less.

    Step Therapy

    Step therapy — Not applicable

    Step therapy does not apply to this policy; coverage is based on meeting quantity-limit criteria and specific approval conditions rather than a step-wise trial of lower quantities or alternatives.

    Documentation Required

    Supportive documentation — examples

    Submit clinical documentation to support that the member meets the approval criteria for >8 kits/365 days.

    • Office chart notes
    • Laboratory results
    • Other clinical information (e.g., provider recommendations or test-related orders)
    Denial Risk

    Documentation required — risk of denial if not provided

    Requests for COVID-19 test kits beyond 8 kits per 365 days must be supported by the required documentation; lack of supporting documentation may result in denial of the request.

    How to Order and Submit Requests

    Note

    Ordering requirements — submit supporting documentation for quantities beyond allowance

    Provider must order the excess kits and submit supporting documentation (such as chart notes, lab results, or other clinical information) that justifies quantities beyond the 8-kit per 365-day allowance.

    • Justification should demonstrate the member meets one of the initial approval criteria (e.g., immunocompromised status, need for frequent testing, recent exposure/recurring symptoms, or high‑risk residence/employment).
    • For continued therapy, include prior authorization history or a letter of medical necessity explaining ongoing need.

    Non‑covered Situations

    Non‑FDA approved indications are not covered by this policy unless there is adequate documentation of efficacy and safety per the Meridian Off‑label Use Policy (CP.PMN.53) or applicable evidence of coverage. Absent that documentation, requests for coverage for non‑FDA indications will be denied.

    Background and Test Description

    At‑home FDA‑authorized over‑the‑counter (OTC) COVID‑19 test kits are intended for self‑testing to detect current SARS‑CoV‑2 infection. Most of these kits are antigen tests that provide rapid results, typically within 15–30 minutes; however, a negative antigen result does not fully exclude infection and repeat testing (for example, 48 hours apart) may be recommended per FDA or manufacturer guidance.

    Definitions

    FDA‑authorized OTC COVID‑19 test kits — definition and typical technology
    DefinitionFDA‑authorized OTC COVID-19 test kits are over-the-counter, at‑home diagnostic tests intended for self-testing to detect current SARS‑CoV‑2 infection
    Common methodologyMost are antigen tests that detect viral proteins
    Result characteristicsA positive result generally indicates current infection; a negative result does not fully rule out infection
    Manufacturer instructionsUsers should follow manufacturer instructions for sample collection, timing, storage, and expiration
    Policy Summary
    PayerMeridian
    PolicyCOVID-19 Test Quantity Limit
    Policy CodePolicy MDN.CP.PMN.357
    Change TypeNo material changes
    Effective DateSep 1, 2026
    Last ReviewJul 10, 2026
    Next Review DateJul 10, 2026
    Key ActionSubmit prior authorization and supporting clinical documentation for requests exceeding 8 COVID-19 test kits per 365 days.
    SourceLink
    On This Page
    Coverage Criteria for Excess COVID-19 Test KitsStandard Allowance and Frequency LimitsPrior Authorization and Documentation RequirementsHow to Order and Submit RequestsNon‑covered SituationsBackground and Test DescriptionDefinitions